Champions Oncology (CSBR) Financials: Revenue & Earnings
CSBR$4.92+0.09 +1.86%
$68.48M
Market Cap
—
P/E
—
Forward P/E
—
Score
Champions Oncology (CSBR) Financials: Revenue & Earnings
CSBR price $4.92 +0.09 +1.86%
- Ticker
- CSBR
- Price
- $4.92
- Change
- +0.09 +1.86%
- Market cap ?
- $68.48M
- Beta ?
- 0.44
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
CSBR fair value $6.74. Price $4.92. Price is 27% below fair value.
Above fair value, but less expensive than usual. A smaller premium than on 73% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 4.98M. Growth 9.83%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 13.92M. Net debt -360.00K. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-15 | — | 0.02 | — | 16.37M |
| 2026-09-10 | 0.05 | -0.01 | 15.23M | 15.04M |
| 2026-07-27 | 0.01 | -0.05 | 13.84M | 12.89M |
| 2026-03-12 | -0.02 | 0.09 | 16.56M | 16.61M |
| 2025-12-15 | 0.02 | 0.08 | 15.04M | 14.04M |
| 2025-09-15 | -0.03 | -0.01 | 13.99M | 13.51M |
| 2025-07-23 | -0.13 | -0.20 | 12.36M | 12.00M |
| 2025-03-11 | 0.31 | -0.01 | 17.04M | 12.90M |
| 2024-12-11 | 0.05 | 0.01 | 13.50M | 13.05M |
| 2024-09-11 | 0.11 | -0.03 | 14.10M | 13.23M |
| 2024-07-18 | -0.01 | -0.16 | 14.00M | 12.70M |
| 2024-03-14 | -0.16 | -0.06 | 12.00M | 13.50M |
| 2023-12-12 | -0.15 | -0.17 | 11.60M | 12.82M |
| 2023-09-13 | -0.19 | -0.10 | 12.60M | 13.10M |
| 2023-07-24 | -0.19 | -0.12 | 13.10M | 12.84M |
| 2023-03-15 | -0.18 | -0.04 | 12.77M | 13.13M |
| 2022-12-13 | 0.01 | -0.01 | 14.30M | 13.79M |
| 2022-09-08 | -0.02 | 0.01 | 13.70M | 13.46M |
| 2022-07-21 | -0.03 | 0.03 | 12.88M | 12.77M |
| 2022-03-15 | 0.05 | 0.03 | 13.20M | 13.03M |
| 2021-12-13 | 0.02 | 0.01 | 11.79M | 12.47M |
| 2021-09-13 | -0.01 | 0.01 | 11.25M | 30.38M |
| 2021-07-22 | -0.04 | 0.01 | 10.56M | 10.97M |
| 2021-03-11 | 0.05 | 0.01 | 10.81M | 10.14M |
| 2020-12-14 | 0.00 | 0.01 | 10.12M | 9.81M |
| 2020-09-14 | 0.01 | 0.02 | 9.55M | 19.09M |
| 2020-07-27 | -0.14 | 0.02 | 8.75M | 624.86K |
| 2020-03-12 | 0.03 | 0.03 | 9.01M | 9.01M |
| 2019-12-16 | 0.02 | -0.02 | 7.62M | 3.81M |
| 2019-09-16 | -0.05 | 0.04 | 6.74M | 4.49M |
| 2019-07-15 | -0.01 | 0.03 | 7.72M | 23.16M |
| 2019-03-18 | -0.03 | 0.03 | 6.43M | 17.36M |
| 2018-12-17 | 0.03 | 0.04 | 6.69M | 8.92M |
| 2018-09-13 | 0.05 | 0.01 | 6.22M | 1.25M |
| 2018-07-26 | -0.04 | -0.04 | 4.92M | 4.92M |
| 2018-03-15 | -0.01 | — | 5.08M | — |
| 2017-12-07 | -0.01 | — | 5.20M | — |
| 2017-09-14 | -0.01 | — | 5.03M | — |
| 2017-07-27 | -0.15 | — | 3.72M | — |
| 2017-03-16 | -0.11 | — | 3.56M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | ACKERMAN JOEL | Buy | 69.79K | $1.60 | 111.67K |
| 2026-10-15 | ACKERMAN JOEL | Sell | 69.79K | $1.60 | 111.67K |
| 2025-11-05 | Breitfeld Philip P. | Buy | 13.79K | $6.80 | 93.77K |
| 2025-11-05 | SIDRANSKY DAVID | Buy | 21.22K | $6.80 | 144.27K |
| 2025-11-05 | Mendelson Daniel Newman | Buy | 13.79K | $6.80 | 93.77K |
| 2025-11-05 | TOBIN SCOTT R | Buy | 25.46K | $6.80 | 173.13K |
| 2025-11-05 | ACKERMAN JOEL | Buy | 21.22K | $6.80 | 144.27K |
| 2025-10-30 | ACKERMAN JOEL | Buy | 94.41K | $2.10 | 198.25K |
| 2025-10-30 | ACKERMAN JOEL | Sell | 94.41K | $2.10 | 198.25K |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 100.00K | $7.80 | 780.00K |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 100.00K | $7.80 | 780.00K |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 150.00K | $7.80 | 1.17M |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 62.50K | $7.80 | 487.50K |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 62.50K | $7.80 | 487.50K |
| 2025-07-16 | Brainin Robert Lawrence | Buy | 225.00K | $7.80 | 1.75M |
| 2025-03-25 | Breitfeld Philip P. | Sell | 4.15K | — | — |
| 2024-11-12 | Brainin Robert Lawrence | Buy | 23.03K | $4.64 | 106.86K |
| 2024-11-12 | Breitfeld Philip P. | Buy | 18.71K | $4.64 | 86.84K |
| 2024-11-12 | SIDRANSKY DAVID | Buy | 21.88K | $4.64 | 101.52K |
| 2024-11-12 | Mendelson Daniel Newman | Buy | 21.59K | $4.64 | 100.18K |
| 2024-11-12 | TOBIN SCOTT R | Buy | 34.55K | $4.64 | 160.31K |
| 2024-11-12 | ACKERMAN JOEL | Buy | 43.19K | $4.64 | 200.40K |
| 2024-10-31 | ACKERMAN JOEL | Buy | 16.67K | $5.43 | 90.50K |
| 2024-10-31 | ACKERMAN JOEL | Buy | 88.47K | $2.10 | 185.79K |
| 2024-10-31 | ACKERMAN JOEL | Sell | 16.67K | $5.43 | 90.50K |
| 2024-10-31 | ACKERMAN JOEL | Sell | 88.47K | $2.10 | 185.79K |
| 2024-01-12 | Mendelson Daniel Newman | Buy | 1.00K | $6.50 | 6.50K |
| 2024-01-11 | Mendelson Daniel Newman | Buy | 2.00K | $6.27 | 12.54K |
| 2024-01-10 | Mendelson Daniel Newman | Buy | 2.94K | $6.31 | 18.58K |
| 2024-01-09 | Mendelson Daniel Newman | Buy | 3.00K | $6.25 | 18.75K |
| 2024-01-08 | Mendelson Daniel Newman | Buy | 1.00K | $6.15 | 6.15K |
| 2024-01-05 | Mendelson Daniel Newman | Buy | 2.00K | $6.09 | 12.18K |
| 2024-01-04 | Mendelson Daniel Newman | Buy | 3.00K | $6.12 | 18.36K |
| 2024-01-03 | Mendelson Daniel Newman | Buy | 500 | $5.83 | 2.92K |
| 2023-12-21 | Mendelson Daniel Newman | Buy | 2.50K | $4.92 | 12.30K |
| 2023-12-20 | Mendelson Daniel Newman | Buy | 2.10K | $4.82 | 10.12K |
| 2023-12-19 | Mendelson Daniel Newman | Buy | 5.00K | $4.75 | 23.75K |
| 2023-11-03 | Brainin Robert Lawrence | Buy | 19.07K | $5.51 | 105.08K |
| 2023-11-03 | TOBIN SCOTT R | Buy | 28.60K | $5.51 | 157.59K |
| 2023-11-03 | ACKERMAN JOEL | Buy | 35.75K | $5.51 | 196.98K |
| 2023-11-03 | Mendelson Daniel Newman | Buy | 26.22K | $5.51 | 144.47K |
| 2023-11-03 | SIDRANSKY DAVID | Buy | 15.49K | $5.51 | 85.38K |
| 2023-11-03 | Breitfeld Philip P. | Buy | 15.49K | $5.51 | 85.38K |
| 2023-10-17 | ACKERMAN JOEL | Buy | 114.55K | $2.10 | 240.56K |
| 2023-10-17 | ACKERMAN JOEL | Sell | 14.55K | $2.10 | 30.56K |
| 2023-10-11 | Mendelson Daniel Newman | Buy | 5.00K | $6.40 | 32.00K |
| 2023-10-10 | Mendelson Daniel Newman | Buy | 1.10K | $6.41 | 7.05K |
| 2023-10-09 | Davis Brady | Buy | 68.00K | $6.50 | 442.00K |
| 2023-10-09 | Davis Brady | Buy | 7.50K | $6.50 | 48.75K |
| 2023-10-09 | Davis Brady | Buy | 135.00K | $6.50 | 877.50K |
| 2023-10-06 | Mendelson Daniel Newman | Buy | 1.53K | $6.48 | 9.91K |
| 2023-10-05 | Mendelson Daniel Newman | Buy | 2.00K | $6.47 | 12.94K |
| 2023-10-04 | Mendelson Daniel Newman | Buy | 5.00K | $6.40 | 32.00K |
| 2023-10-03 | Mendelson Daniel Newman | Buy | 2.50K | $6.30 | 15.75K |
| 2023-09-29 | Mendelson Daniel Newman | Buy | 4.00K | $6.16 | 24.64K |
| 2023-09-28 | Mendelson Daniel Newman | Buy | 5.00K | $6.22 | 31.10K |
| 2023-09-27 | Mendelson Daniel Newman | Buy | 1.50K | $5.95 | 8.93K |
| 2023-09-26 | Mendelson Daniel Newman | Buy | 5.00K | $5.65 | 28.25K |
| 2023-09-22 | Mendelson Daniel Newman | Buy | 3.81K | $5.50 | 20.97K |
| 2023-09-21 | Mendelson Daniel Newman | Buy | 5.00K | $5.51 | 27.55K |
| 2023-09-20 | Mendelson Daniel Newman | Buy | 4.02K | $5.51 | 22.14K |
| 2023-09-19 | Mendelson Daniel Newman | Buy | 5.00K | $5.28 | 26.40K |
| 2023-03-17 | Morris Ronnie | Buy | 12.38K | $4.04 | 49.97K |
| 2022-11-01 | Brainin Robert Lawrence | Buy | 14.13K | $7.00 | 98.91K |
| 2022-11-01 | ACKERMAN JOEL | Buy | 26.50K | $7.00 | 185.50K |
| 2022-11-01 | Breitfeld Philip P. | Buy | 11.48K | $7.00 | 80.36K |
| 2022-11-01 | Mendelson Daniel Newman | Buy | 19.43K | $7.00 | 136.01K |
| 2022-11-01 | SIDRANSKY DAVID | Buy | 11.48K | $7.00 | 80.36K |
| 2022-11-01 | TOBIN SCOTT R | Buy | 21.20K | $7.00 | 148.40K |
| 2022-10-19 | ACKERMAN JOEL | Buy | 16.67K | $3.21 | 53.50K |
| 2022-10-19 | ACKERMAN JOEL | Buy | 16.67K | $3.21 | 53.50K |
| 2022-10-19 | ACKERMAN JOEL | Buy | 16.67K | $3.21 | 53.50K |
| 2022-10-12 | SIDRANSKY DAVID | Buy | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | SIDRANSKY DAVID | Sell | 3.56K | $7.51 | 26.75K |
| 2022-10-12 | SIDRANSKY DAVID | Sell | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | SIDRANSKY DAVID | Sell | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | Breitfeld Philip P. | Buy | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | Breitfeld Philip P. | Sell | 3.56K | $7.51 | 26.75K |
| 2022-10-12 | Breitfeld Philip P. | Sell | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | Breitfeld Philip P. | Sell | 8.33K | $3.21 | 26.75K |
| 2022-10-12 | TOBIN SCOTT R | Buy | 10.00K | $3.21 | 32.10K |
| 2022-10-12 | TOBIN SCOTT R | Sell | 10.00K | $3.21 | 32.10K |
| 2022-10-12 | TOBIN SCOTT R | Sell | 10.00K | $3.21 | 32.10K |
| 2021-11-05 | Brainin Robert Lawrence | Buy | 9.90K | $10.10 | 100.00K |
| 2021-11-05 | SIDRANSKY DAVID | Buy | 8.04K | $10.10 | 81.25K |
| 2021-11-05 | Mendelson Daniel Newman | Buy | 13.61K | $10.10 | 137.50K |
| 2021-11-05 | Breitfeld Philip P. | Buy | 8.04K | $10.10 | 81.25K |
| 2021-11-05 | ACKERMAN JOEL | Buy | 18.56K | $10.10 | 187.50K |
| 2021-11-05 | TOBIN SCOTT R | Buy | 14.85K | $10.10 | 150.00K |
| 2021-10-15 | SIDRANSKY DAVID | Buy | 16.67K | $1.59 | 26.50K |
| 2021-10-15 | SIDRANSKY DAVID | Buy | 2.63K | $10.08 | 26.50K |
| 2021-10-15 | SIDRANSKY DAVID | Buy | 16.67K | $1.59 | 26.50K |
| 2021-10-12 | TOBIN SCOTT R | Buy | 10.00K | $1.59 | 15.90K |
| 2021-10-12 | TOBIN SCOTT R | Sell | 10.00K | $1.59 | 15.90K |
| 2021-06-09 | Brainin Robert Lawrence | Other | 8.03K | $9.27 | 74.46K |
| 2021-03-23 | Breitfeld Philip P. | Buy | 4.17K | $3.65 | 15.21K |
| 2021-03-23 | Breitfeld Philip P. | Sell | 1.34K | $11.35 | 15.21K |
| 2021-03-23 | Breitfeld Philip P. | Sell | 4.17K | $3.65 | 15.21K |
| 2021-01-19 | Poliakoff Abba David | Buy | 10.00K | $5.43 | 54.30K |
| 2021-01-19 | Poliakoff Abba David | Buy | 8.87K | $11.53 | 102.31K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 27, holders +2 vs prior quarter. Ownership 42.58%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 2.42M | 0 | 0.00% | 14.92M |
| NEA MANAGEMENT COMPANY, LLC | 1.71M | 0 | 0.00% | 10.56M |
| VANGUARD CAPITAL MANAGEMENT LLC | 301.35K | 1.83K | +0.61% | 1.86M |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 295.66K | -24.02K | -7.51% | 1.82M |
| MORGAN STANLEY | 235.40K | -6.90K | -2.85% | 1.45M |
| BANK OF AMERICA CORP /DE/ | 214.06K | 192.22K | +880.43% | 1.32M |
| RENAISSANCE TECHNOLOGIES LLC | 139.04K | -6.50K | -4.47% | 856.48K |
| BLACKROCK, INC. | 129.85K | 5.95K | +4.80% | 799.86K |
| MINK BROOK ASSET MANAGEMENT LLC | 111.34K | 0 | 0.00% | 685.84K |
| GEODE CAPITAL MANAGEMENT, LLC | 76.30K | -877 | -1.14% | 470.12K |
| HIGHTOWER ADVISORS, LLC | 41.90K | 6.74K | +19.18% | 258.11K |
| VANGUARD FIDUCIARY TRUST CO | 33.24K | 247 | +0.75% | 204.75K |
| NORTHERN TRUST CORP | 27.91K | -18.02K | -39.24% | 171.93K |
| STATE STREET CORP | 26.20K | 0 | 0.00% | 161.41K |
| BANK OF NEW YORK MELLON CORP | 21.61K | 0 | 0.00% | 133.14K |
| ACADIAN ASSET MANAGEMENT LLC | 20.52K | -800 | -3.75% | 125.00K |
| CITADEL ADVISORS LLC | 18.30K | 18.30K | New | 112.70K |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 18.22K | -28 | -0.15% | 112.24K |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 15.80K | 0 | 0.00% | 97.33K |
| MERCER GLOBAL ADVISORS INC /ADV | 12.78K | 12.78K | New | 78.69K |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 12.25K | 0 | 0.00% | 75.00K |
| VANGUARD GLOBAL ADVISERS, LLC | 2.09K | 0 | 0.00% | 12.89K |
| BARCLAYS PLC | 13 | 13 | New | 80 |
| JPMORGAN CHASE & CO | 11 | 0 | 0.00% | 71 |
| CASSADAY & CO WEALTH MANAGEMENT LLC | 10 | 0 | 0.00% | 62 |
Earnings and financials
Champions Oncology, Inc. (CSBR) trades at $4.92, with a market cap of $68.48M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn